An interventional study of Experimental arm and Control arm in Rectal Surgery, Pain (Visceral, Somatic, or Neuropathic) and Vagal Nerve Stimulation, sponsored by University Hospital, Angers. Recruiting at 1 site in France. Open to participants aged 18 Years to 120 Years. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by University Hospital, Angers · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 482 studies in Pain with a site in France — 75 open to participants now, 79 under way, 8 of them phase 3. Pain · France.
Among the 482 studies in Pain with a site in France, this one is the 245th largest by planned enrollment of the 369 interventional ones that give a count, is one of 28 that started in 2026, is one of 225 with no phase, reaches primary completion later than 52 of the 78 other live ones, and was the 473rd registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →75 of the 482 studies in Pain with a site in France are open now. Recruiting first, the newest first:
University Hospital, Clermont-Ferrand · Sites in France
Ages 18+
Farraj Miguel · Sites in France, Belgium
Ages 18+
University Hospital, Toulouse · Sites in France
Ages 18+
University Hospital, Limoges · Sites in France
Ages 18–50 · Women only
Teleflex · Sites in France, United States, Latvia and 1 more country
Ages 18–80
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years to 120 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
482 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 33 · Phase 3 83 · Phase 4 29
First in 2000; this study’s year is marked. 28 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 80 across the 369 interventional studies, 100 across the 112 observational. Of the 350 that completed or were terminated, 31 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
68 of 482 have an industry lead sponsor. The 10 most frequent:
University Hospital, Angers is the lead sponsor of 481 studies on the registry; 122 are open to participants now.
University Hospital, Angers has 9 studies filed under Pain — fewer than ten, so there is no comparison to draw.
24 of the studies in Pain with a site in France that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06381063Phase 3Centre Hospitalier Universitaire, AmiensNon-steroidal Anti-inflammatory in Cardiac Surgery | 2027-03 |
| NCT06917651Phase 3University Hospital, Clermont-FerrandManagement of Moderate to Severe Monotraumatic Pain With Sublingual Sufentanil in an Emergency Situation. | 2027-04-22 |
| NCT07668050University Hospital, Clermont-FerrandA Study of the Impact of a Virtual Reality Medical Device (HypnoVR® Headset) on Anxiety and Pain in Interventional Radiology. | 2026-12 |
| NCT06779812Clinique BizetImpact of Auriculotherapy on Postoperative Pain in Patients Undergoing Surgery for SCC | 2026-12 |
| NCT07627490University Hospital, ToulouseThe Potential of Transcutaneous Electrical Nerve Stimulation to Improve Pain Experienced During Posterior Branch Blocks in Patients With Lumbar Posterior Joint Syndrome | 2026-12-01 |
Add all 24 to your calendar (.ics) → With an account.
Among the 482 studies in Pain with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Anorectal surgery is a type of surgery that can cause anal pain, particularly in the context of hemorrhoid surgery or anal fissure surgery. Generally, the period of discomfort related to the pain lasts about two weeks. There is a nerve (the vagus nerve) whose stimulation via a probe placed in the ear can reduce stress and chronic pain. Its ease of use makes it a promising tool for treating pain. Vagal auricular stimulation could be an interesting option in the management of postoperative pain of the anus and rectum. Its efficacy or feasibility in this context has never been evaluated.
The aim of this study is to evaluate the feasibility in this context and to assess the extend of pain reduction associated with perioperative nerve vagus stimulation by a medical device (Transcutaneous Electrical Nerve Stimulator (TENS ECO Plus)). It is offered to adult patients undergoing transanal anal or rectal surgery on an outpatient or inpatient basis as part of a scheduled procedure.
Patients to be included in the study are selected during the initial pre-operative consultation with the surgeon. Once the surgical indication is confirmed and the patient fulfills the study eligibility criteria, the investigator provides them with oral information about the study. The patient is also given an information sheet (written in language understandable to the patient) and a consent form.
During this initial visit, demographic data and information regarding the surgical indication are collected.
Stimulation begins two days before surgery (twice daily), followed by stimulation on the morning of surgery, one hour before arrival in the operating room. Successful completion of the stimulation, as well as any complications, are recorded in the patient diary.
On the day of surgery (day 0), data concerning the procedure and the maximum visual analogue scale (VAS) are collected in the recovery room. Analgesic consumption is also recorded.
On the evening of the procedure, stimulation is performed and adherence is recorded.
Maximum and mean VAS are collected on postoperative day 1 and then daily in the patient diary for 15 days.
Vagus nerve stimulation is performed morning and evening for 15 days. VAS scores, adherence, analgesic consumption, the date of the first bowel movement and its painfulness, as well as any complications related to the stimulation are noted in the patient diary. On day 3 (+/- 2 days) after the procedure, and at the end of the 15-day postoperative period, the patient will be contacted by phone or text message by the investigator team to remind them to complete the notebook.
On day 30 (+/- 5 days), the patient returns for a follow-up visit. The patient diary and equipment are collected. Complications are recorded, as well as quality of life during the postoperative month (SF-36 form).
For patients, the expected benefits are significant, as postoperative quality of life is expected to improve through reduced pain. Furthermore, decreasing the use of step II and III analgesics should shorten the recovery period and promote better overall recovery.
Inclusion Criteria:
Exclusion Criteria:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
assessment of rectal post operative pain with active nerve vagus stimulation
Device: Experimental arm
assessment of rectal post operative pain without active nerve vagus stimulation
Device: Control arm
active vagus nerve stimulation
no active vagus nerve stimulation
Change of pain after perioperative auricular vagus nerve stimulation
The intensity of anal pain is measured by the Visual Analog Scale (VAS) from 0 to 10 in the recovery room and then every day for 15 days. This VAS is assessed in patients treated with auricular vagus active nerve stimulation and in patients with a inactive device. The higher score means a worse outcome.
Time frame: day 0, day 1, day 2, day 3, day 4, day 5, day 6, day 7, day 8, day 9, day 10, day 11, day 12, day 13, day 14, day 15
consumption of analgesic
the post-operative consumption of analgesic is evaluated in the recovery room (day 0) and then every day for 15 days. Post-operative consumption is assessed in patients treated with auricular vagus active nerve stimulation and in patients with a inactive device.
Time frame: From Day 0 to Day 15
Delay in gastrointestinal motility recovery (passage of stool) and post-defecatory pain
The gastrointestinal transit recovery after surgery is recorded in the patients treated with active device and in patients treated with inactive device. Post defecatory pain more than 30 min is also reported in the patients with active and with inactive device.
Time frame: from day 0 to day 30
Quality of life of patients after surgery
quality of life by health survey SF 36 (the 36-item Short Form Health Survey) is assessed at the day 30 after surgery in the two groups of patients (active device and no active device). SF 36 covers eight health domains: physical functioning (10 items), bodily pain (2 items), role limitations due to physical health problems (4 items), role limitations due to personal or emotional problems (4 items), emotional well-being (5 items), social functioning (2 items), energy/fatigue (4 items), and general health perceptions (5 items). Scores for each domain range from 0 to 100, with a higher score defining a more favorable health state.
Time frame: Day 30
adverse events
adverse events occuring during the first month after surgery and specifically related to the surgery are collected by the investigator for the two groups of patients
Time frame: day 30
acceptability of perioperative auricular vagus nerve stimulation by the patient
The acceptability of treatment by perioperative auricular vagal stimulation is assessed at day 15 by asked question to the two groups of patients. The question is "do you think that the treatment with vagus nerve stimulation is non-binding?"
Time frame: day 15
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2026 (actual). Primary completion is estimated for Oct 2027, 12 months after the start.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 12 months is above that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 29, 2026: start Nov 2026 → Oct 2026, primary completion Nov 2027 → Oct 2027 and completion Jan 2028 → Mar 2028.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.